Through large cohort survival analysis of DDX3 at transcriptome level, we identified that DDX3 RNA level could predict prognosis in colorectal cancer, breast cancer, and head and neck cancer in either or both of RNA sequencing analysis and RNA microarray analysis. Here, DDX3X is linked to head and neck cancer.